Study of the Correlation Between IGF-I and Glycaemic Control in Type 1 Diabetes

Zarghami N; Khosrowbeygi A; Eshtiaghi R; Dayer D

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Current Issue All Issues In Press Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Study of the Correlation Between IGF-I and Glycaemic Control in Type 1 Diabetes

Author(s):

Zarghami N¹,

Khosrowbeygi A²,

Eshtiaghi R³,

Dayer D³

1Department of Clinical Biochemistry and RIA, Drug Applied Research Center, *, IR. Iran

2Department of Clinical Biochemistry and RIA, Drug Applied Research Center, IR. Iran

3Department of Internal Medicine, Endocrine Unit, Imam Hospital, Urumia University of Medical Sciences, IR. Iran

International Journal of Endocrinology and Metabolism:Vol. 2, issue 1; 13-18

Article type:Research Article

Received:Jan 01, 2003

Accepted:Feb 01, 2004

How to Cite:Zarghami NKhosrowbeygi AEshtiaghi RDayer DStudy of the Correlation Between IGF-I and Glycaemic Control in Type 1 Diabetes.Int J Endocrinol Metab.2(1):13-18.

Abstract

Diabetes is a common endocrine disease and its complications are major stimuli for the enhancment of efforts towards its control. At present, glycosylated hemoglobin (HbAlc) is used for long term control of glucose levels in diabetic patients, but due to lack of availability of a standard control method, recent findings suggest that insulin-like growth factor-I (IGF-I) may be used as a biomarker for glycaemic control. The aim of this study was to examine the correlation between IGF-I and glycaemic control measured as fasting plasma glucose (FPG) and HbAlc in Type 1 diabetes.
Materials and Methods:We designed a crosssectional case-control study with systematic random sampling. The study included 26 newly diagnosed patients with Type 1 diabetes (15 male and 11 female; mean age 23.7±9.1years) and 26 healthy controls (9 male and 17 female; mean age 24.1±4.4years). The concentrations of FPG, IGF-I, HbAlc and IGF-binding protein-3 (IGFBP-3)were measured in both groups. FPG was measured by the enzymatic glucose oxidase method and the colorimetric method was used to measure HbAlc. Determination of serum IGF-I and IGFBP-3 total levels was carried out using immunoassay.

Keywords

Full Text

Full text is available in PDF

comments